1. Kasahara M, Umeshita K, Inomata Y, et al.: Long-term outcomes of pediatric living donor liver transplantation in Japan: an analysis of more than 2200 cases listed in the registry of the Japanese Liver Transplantation Society. Am J Transplant 2013;13(7):1830-1839.
2. Lee SG, Hwang S, Kim KH, et al.: Toward 300 liver transplants a year. Surg Today 2009;39(5):367-373.
3. Schramm C, Bubenheim M, Adam R, et al.: Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry. Liver Transpl 2010;16(4):461-469.
4. Umeshita K, Eguchi S, Egawa H, et al.: Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society. Hepatol Res 2019;49(9):964-980.
5. Bilir BM, Guinette D, Karrer F, et al.: Hepatocyte transplantation in acute liver failure. Liver Transpl 2000;6(1):32-40.
6. Strom SC, Bruzzone P, Cai H, et al.: Hepatocyte transplantation: clinical experience and potential for future use. Cell Transplant 2006;15 Suppl 1:S105-110.
7. Ibars EP, Cortes M, Tolosa L, et al.: Hepatocyte transplantation program: Lessons learned and future strategies. World J Gastroenterol 2016;22(2):874-886.
8. Jorns C, Ellis EC, Nowak G, et al.: Hepatocyte transplantation for inherited metabolic diseases of the liver. J Intern Med 2012;272(3):201-223.
9. Yoshida S, Yamagata Y, Murayama K, et al.: The influence of collagen III expression on the efficiency of cell isolation with the use of collagenase H. Transplant Proc 2014;46(6):1942-1944.
10. Fukuoka K, Inagaki A, Nakamura Y, et al.: The Optimization of Short-Term Hepatocyte Preservation Before Transplantation. Transplant Direct 2017;3(7):e176.
11. Ogasawara H, Inagaki A, Fathi I, et al.: Preferable Transplant Site for Hepatocyte Transplantation in a Rat Model. Cell Transplant 2021;30:9636897211040012.
12. Saitoh Y, Inagaki A, Fathi I, et al.: Improvement of hepatocyte engraftment by co-transplantation with pancreatic islets in hepatocyte transplantation. J Tissue Eng Regen Med 2021;15:361-374.
13. Hamman KJ, Winn SR, Harding CO: Hepatocytes from wild-type or heterozygous donors are equally effective in achieving successful therapeutic liver repopulation in murine phenylketonuria (PKU). Mol Genet Metab 2011;104(3):235- 240.
14. Zhang J, Liu Y, Chen Y, et al.: Adipose-Derived Stem Cells: Current Applications and Future Directions in the Regeneration of Multiple Tissues. Stem Cells Int 2020;2020:8810813.
15. Rodriguez AM, Pisani D, Dechesne CA, et al.: Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 2005;201(9):1397-1405.
16. Jang S, Cho HH, Cho YB, et al.: Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin. BMC Cell Biol 2010;11:25.
17. Najimi M, Khuu DN, Lysy PA, et al.: Adult-derived human liver mesenchymal- like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant 2007;16(7):717-728.
18. Wankhade UD, Shen M, Kolhe R, et al.: Advances in Adipose-Derived Stem Cells Isolation, Characterization, and Application in Regenerative Tissue Engineering. Stem Cells Int 2016;2016:3206807.
19. Nie C, Yang D, Xu J, et al.: Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant 2011;20(2):205-216.
20. Yang Y, Lin H, Shen H, et al.: Mesenchymal stem cell-derived extracellular matrix enhances chondrogenic phenotype of and cartilage formation by encapsulated chondrocytes in vitro and in vivo. Acta Biomater 2018;69:71-82.
21. Xiao B, Rao F, Guo ZY, et al.: Extracellular matrix from human umbilical cord- derived mesenchymal stem cells as a scaffold for peripheral nerve regeneration. Neural Regen Res 2016;11(7):1172-1179.
22. Chen Y, Li C, Li C, et al.: Tailorable Hydrogel Improves Retention and Cardioprotection of Intramyocardial Transplanted Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice. J Am Heart Assoc 2020;9(2):e013784.
23. Ge Y, Zhang Q, Li H, et al.: Adipose-derived stem cells alleviate liver apoptosis induced by ischemia-reperfusion and laparoscopic hepatectomy in swine. Sci Rep 2018;8(1):16878.
24. van Poll D, Parekkadan B, Cho CH, et al.: Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008;47(5):1634-1643.
25. Fitzpatrick E, Wu Y, Dhadda P, et al.: Coculture with mesenchymal stem cells results in improved viability and function of human hepatocytes. Cell Transplant 2015;24(1):73-83.
26. Hansel MC, Gramignoli R, Skvorak KJ, et al.: The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients. Curr Protoc Toxicol 2014;62:14.12.11-23.
27. Matsumura M, Imura T, Inagaki A, et al.: A Simple and Useful Predictive Assay for Evaluating the Quality of Isolated Hepatocytes for Hepatocyte Transplantation. Sci Rep 2019;9(1):6166.
28. Lee CA, Dhawan A, Smith RA, et al.: Instant Blood-Mediated Inflammatory Reaction in Hepatocyte Transplantation: Current Status and Future Perspectives. Cell Transplant 2016;25(7):1227-1236.
29. Yamada S, Shimada M, Utsunomiya T, et al.: Trophic effect of adipose tissue- derived stem cells on porcine islet cells. J Surg Res 2014;187(2):667-672.
30. Yeung TY, Seeberger KL, Kin T, et al.: Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One 2012;7(5):e38189.
31. Ohmura Y, Tanemura M, Kawaguchi N, et al.: Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice. Transplantation 2010;90(12):1366- 1373.
32. Sakata N, Goto M, Yoshimatsu G, et al.: Utility of co-transplanting mesenchymal stem cells in islet transplantation. World J Gastroenterol 2011;17(47):5150-5155.
33. Bunnell BA, Flaat M, Gagliardi C, et al.: Adipose-derived stem cells: isolation, expansion and differentiation. Methods 2008;45(2):115-120.
34. Bourin P, Bunnell BA, Casteilla L, et al.: Stromal cells from the adipose tissue- derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 2013;15(6):641-648.
35. Dominici M, Le Blanc K, Mueller I, et al.: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8(4):315-317.
36. Zhu XQ, Pan XH, Yao L, et al.: Converting Skin Fibroblasts into Hepatic-like Cells by Transient Programming. J Cell Biochem 2016;117(3):589-598.
37. Enosawa S, Suzuki S, Kakefuda T, et al.: Ammonia removal activity of agarose- encapsulated rat hepatocytes. Cell Transplant 1995;4 Suppl 1:S29-31.
38. Enosawa S, Suzuki S, Kakefuda T, et al.: Examination of 7-ethoxycoumarin deethylation and ammonia removal activities in 31 hepatocyte cell lines. Cell Transplant 1996;5(5 Suppl 1):S39-40.
39. Kyurkchiev D, Bochev I, Ivanova-Todorova E, et al.: Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells 2014;6(5):552-570.
40. Yan W, Lin C, Guo Y, et al.: N-Cadherin Overexpression Mobilizes the Protective Effects of Mesenchymal Stromal Cells Against Ischemic Heart Injury Through a β- Catenin-Dependent Manner. Circ Res 2020;126(7):857-874.
41. Coppin L, Sokal E, Stéphenne X: Thrombogenic Risk Induced by Intravascular Mesenchymal Stem Cell Therapy: Current Status and Future Perspectives. Cells 2019;8(10)
42. Bhargava R, Senior PA, Ackerman TE, et al.: Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes 2004;53(5):1311-1317.
43. Maffi P, Angeli E, Bertuzzi F, et al.: Minimal focal steatosis of liver after islet transplantation in humans: a long-term study. Cell Transplant 2005;14(10):727-733.
44. Negi S, Jetha A, Aikin R, et al.: Analysis of beta-cell gene expression reveals inflammatory signaling and evidence of dedifferentiation following human islet isolation and culture. PLoS One 2012;7(1):e30415.
45. Tsung A, Klune JR, Zhang X, et al.: HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007;204(12):2913-2923.
46. Saito Y, Goto M, Maya K, et al.: Brain death in combination with warm ischemic stress during isolation procedures induces the expression of crucial inflammatory mediators in the isolated islets. Cell Transplant 2010;19(6):775-782.
47. Goto M, Imura T, Inagaki A, et al.: The impact of ischemic stress on the quality of isolated pancreatic islets. Transplant Proc 2010;42(6):2040-2042.
48. Moll G, Ankrum JA, Kamhieh-Milz J, et al.: Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines. Trends Mol Med 2019;25(2):149-163.
49. Uematsu SS, Inagaki A, Nakamura Y, et al.: The Optimization of the Prevascularization Procedures for Improving Subcutaneous Islet Engraftment. Transplantation 2018;102(3):387-395.
50. Yasunami Y, Nakafusa Y, Nitta N, et al.: A Novel Subcutaneous Site of Islet Transplantation Superior to the Liver. Transplantation 2018;102(6):945-952.
51. Sakata N, Aoki T, Yoshimatsu G, et al.: Strategy for clinical setting in intramuscular and subcutaneous islet transplantation. Diabetes Metab Res Rev 2014;30(1):1-10.
52. Rafael E, Tibell A, Rydén M, et al.: Intramuscular autotransplantation of pancreatic islets in a 7-year-old child: a 2-year follow-up. Am J Transplant 2008;8(2):458-462.
53. Bissig KD, Le TT, Woods NB, et al.: Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc Natl Acad Sci U S A 2007;104(51):20507-20511.
54. Garcia GE, Xia Y, Chen S, et al.: NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS. J Leukoc Biol 2000;67(4):577-584.
55. Furie MB, Randolph GJ: Chemokines and tissue injury. Am J Pathol 1995;146(6):1287-1301.
56. Wilson GC, Kuboki S, Freeman CM, et al.: CXC chemokines function as a rheostat for hepatocyte proliferation and liver regeneration. PLoS One 2015;10(3):e0120092.
57. Chandrasekar B, Smith JB, Freeman GL: Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 2001;103(18):2296-2302.
58. Cressman DE, Greenbaum LE, DeAngelis RA, et al.: Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274(5291):1379-1383.
59. Fujii M, Yamanouchi K, Sakai Y, et al.: In vivo construction of liver tissue by implantation of a hepatic non-parenchymal/adipose-derived stem cell sheet. J Tissue Eng Regen Med 2018;12(1):e287-e295.
60. Jiao Z, Ma Y, Liu X, et al.: Adipose-Derived Stem Cell Transplantation Attenuates Inflammation and Promotes Liver Regeneration after Ischemia- Reperfusion and Hemihepatectomy in Swine. Stem Cells Int 2019;2019:2489584.
61. Ito T, Itakura S, Todorov I, et al.: Mesenchymal stem cell and islet co- transplantation promotes graft revascularization and function. Transplantation 2010;89(12):1438-1445.
62. Boumaza I, Srinivasan S, Witt WT, et al.: Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. J Autoimmun 2009;32(1):33-42.
63. Montanari E, Meier RPH, Mahou R, et al.: Multipotent mesenchymal stromal cells enhance insulin secretion from human islets via N-cadherin interaction and prolong function of transplanted encapsulated islets in mice. Stem Cell Res Ther 2017;8(1):199.
64. Li J, Hansen KC, Zhang Y, et al.: Rejuvenation of chondrogenic potential in a young stem cell microenvironment. Biomaterials 2014;35(2):642-653.
65. Zuk PA, Zhu M, Ashjian P, et al.: Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13(12):4279-4295.
66. Zuk PA, Zhu M, Mizuno H, et al.: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7(2):211-228.
論文の公開元へ
